PubMed Journals Articles About "Late John Mendlein Joins Reinventing Biotech Lineup April" RSS

06:24 EDT 21st October 2014 | BioPortfolio

Late John Mendlein Joins Reinventing Biotech Lineup April PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Late John Mendlein Joins Reinventing Biotech Lineup April articles that have been published worldwide.

More Information about "Late John Mendlein Joins Reinventing Biotech Lineup April" on BioPortfolio

We have published hundreds of Late John Mendlein Joins Reinventing Biotech Lineup April news stories on BioPortfolio along with dozens of Late John Mendlein Joins Reinventing Biotech Lineup April Clinical Trials and PubMed Articles about Late John Mendlein Joins Reinventing Biotech Lineup April for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Late John Mendlein Joins Reinventing Biotech Lineup April Companies in our database. You can also find out about relevant Late John Mendlein Joins Reinventing Biotech Lineup April Drugs and Medications on this site too.

Showing "Late John Mendlein Joins Reinventing Biotech Lineup April" PubMed Articles 1–25 of 3,800+

Extremely Relevant

Biotech drugs too little, too late for Ebola outbreak.

Suspect Filler Similarity in Eyewitness Lineups: A Literature Review and a Novel Methodology.

Eyewitness lineups typically contain a suspect (guilty or innocent) and fillers (known innocents). The degree to which fillers should resemble the suspect is a complex issue that has yet to be resolved. Previously, researchers have voiced concern that eyewitnesses would be unable to identify their target from a lineup containing highly similar fillers; however, our literature review suggests highly similar fillers have only rarely been shown to have this effect. To further examine the effect of highly simil...

Relevant

Double-Blind Photo Lineups Using Actual Eyewitnesses: An Experimental Test of a Sequential Versus Simultaneous Lineup Procedure.

Eyewitnesses (494) to actual crimes in 4 police jurisdictions were randomly assigned to view simultaneous or sequential photo lineups using laptop computers and double-blind administration. The sequential procedure used in the field experiment mimicked how it is conducted in actual practice (e.g., using a continuation rule, witness does not know how many photos are to be viewed, witnesses resolve any multiple identifications), which is not how most lab experiments have tested the sequential lineup. No signi...

Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL.

Current HIV-1 vaccines based on the HIV-1 envelope glycoprotein spike (Env), the only relevant target for broadly neutralizing antibodies, are unable to induce protective immunity. Env immunogenicity can be enhanced by fusion to costimulatory molecules involved in B cell activation, such as APRIL and CD40L. Here, we found that Env-APRIL signaled through the two receptors, BCMA and TACI. In rabbits, Env-APRIL induced significantly higher antibody responses against Env compared to unconjugated Env, while the ...

Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.

Cytokines play an important role in the pathogenesis of systemic lupus erythematosus (SLE). Among the cytokines that regulate B cell homeostasis is a proliferation-inducing ligand (APRIL). This study aimed to determine whether serum levels of APRIL are raised in patients with SLE and correlate with disease activity or proinflammatory cytokines production, or both. Serum APRIL, interleukin-17 (IL-17), IL-4 and interferon gamma (IFN-γ) levels were measured in forty patients with SLE and 30 healthy controls. ...

Reinventing the Health Services Researcher.

Reinventing neutron science in Europe.

Reinventing adherent cell culture monitoring.

Biotech methods and advances.

Cover illustration: Our latest Biotech Methods & Advances special issue is edited by our Editors-in-Chief Prof. Alois Jungbauer and Prof. Sang Yup Lee. As always, the special issue is a collection of the latest breakthroughs in biotechnology. The cover is a graphical representation of some of the tools in biotechnology research. Image: © Bank-Bank - Fotolia.com.

Editorial: Latest methods and advances in biotechnology.

The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our Editors-in-Chief, Prof. Sang Yup Lee and Prof. Alois Jungbauer and covers a wide array of topics in biotechnology, including the perennial favorite workhorses of the biotech industry, Chinese hamster ovary (CHO) cell and Escherichia coli.

John St John Long: quackery and manslaughter.

University biotech patenting 2013.

Public biotech 2013-the numbers.

Benchmarking biotech and pharmaceutical product development.

Erratum: University biotech patenting 2013.

What's fueling the biotech engine-2012 to 2013.

Taiwan biotech buoyed by colossal financings.

Biotech patents and science policy: the Spanish experience.

Improving biotech education through gamified laboratory simulations.

Small biotech steers HDAC inhibitor to clinic.

Erratum: Biotech's wellspring: the health of private biotech in 2013.

The cost of kidney transplant over time.

Background-Kidney transplant improves quality of life and survival compared with dialysis. Despite advances in immunosuppressant regimens and the prevention and treatment of acute rejection, graft survival rates have not improved significantly in the past decade. Although the clinical effectiveness of these regimens has been studied, the impact of changes over time on cost has not.Methods-Costs of kidney transplant were compared between 2 periods demarcated by a programmatic change from cyclosporine (early)...

Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in Switzerland.

We sought to identify reasons for late human immunodeficiency virus (HIV) testing or late presentation for care.

Occupations that People with Late Effects of Polio Perceive Difficult to Perform.

The aims of this study were to describe which occupations that people with late effects of polio perceive difficult to perform, which occupational area the occupations were related to and their level of complexity. The aims were also to describe their own perception of the importance, performance and satisfaction with these occupations. Sixty-two participants (mean age 61 years) were assessed with the Canadian Occupational Performance Measure. A total of 431 occupations were reported (43% self-care, 32% p...

Guidance for performing multivariate data analysis of bioprocessing data: Pitfalls and recommendations.

Biotech unit operations are often characterized by a large number of inputs (operational parameters) and outputs (performance parameters) along with complex correlations amongst them. A typical biotech process starts with the vial of the cell bank, ends with the final product and has anywhere from 15-30 such unit operations in series. Besides the above-mentioned operational parameters, raw material attributes can also impact process performance and product quality as well as interact amongst each other. Mul...


Search BioPortfolio:
Loading
Advertisement
Advertisement

PubMed Database Quicklinks